Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis.
about
Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management.Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease.Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity.Lipotoxicity: Many Roads to Cell Dysfunction and Cell Death: Introduction to a Thematic Review Series.Mixed-lineage kinase 3 pharmacological inhibition attenuates murine nonalcoholic steatohepatitis.Cell culture models of fatty acid overload: Problems and solutions.Identification of the genomic region under epigenetic regulation during non-alcoholic fatty liver disease progression.Deletion of endoplasmic reticulum stress-responsive co-chaperone p58IPK protects mice from diet-induced steatohepatitis.Manifestations and mechanisms of myocardial lipotoxicity in obesity.Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation.p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine.TRAIL Deletion Prevents Liver, but Not Adipose Tissue, Inflammation during Murine Diet-Induced Obesity.Proapoptotic signaling induced by deletion of receptor-interacting kinase 1 and TNF receptor-associated factor 2 results in liver carcinogenesis.To die or not to die: death signaling in nonalcoholic fatty liver disease.Apoptosis and non-alcoholic fatty liver diseases.Non-alcoholic fatty liver diseaseNon-alcoholic fatty liver disease: Insights from sphingolipidomicsMolecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular CarcinomaPathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches
P2860
Q30234574-D6F8B5F3-BE80-4FA8-BE59-B9AB2654FB48Q36083468-7F6EA6F8-0289-4309-85DB-28F957F44E5BQ38687132-428BF8FE-E7D3-4212-A9C3-A8B88CB991A3Q38853738-1CA93580-6B77-4357-9BC3-B2C052D8657FQ41252411-A001C3A6-73FC-4FFE-82C5-77E80D207220Q46258336-F3B848CD-36C5-420A-8289-5C526E872737Q47615586-802B8EFD-70E8-4938-A221-7891F2C9A10EQ47743188-75049B39-6DAE-47AD-A79F-82AB43EAD8EBQ48249334-E72A530D-5DD3-4C91-B648-FF28ED096C35Q49790075-3CD91CBF-51B4-4881-BA3B-B739E05BBB06Q51761242-101CAE18-786E-4533-8F18-AB8ECD1AE993Q52745207-7232EAD7-99E4-4212-9B79-1928688AA93DQ53186550-07318389-3A48-45BB-8F92-32D0CE2C426FQ54119547-D9C0D55C-884C-4044-85D3-C3AE25B1C6F9Q55503094-F5C1DE5B-AFAC-43B1-9A8F-84FEA79E766BQ56003593-BF1D70F4-C962-46F9-85CE-B5E31A6B6240Q57182443-68DADA08-D15E-4210-A6FB-90030351DAFEQ58693431-56E264F3-2201-4B73-8F45-34E542F75B2CQ58705640-51BA0035-89E5-4B99-A813-24D586CBCFB9
P2860
Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Lipotoxic lethal and sublethal ...... elevance to NASH pathogenesis.
@en
type
label
Lipotoxic lethal and sublethal ...... elevance to NASH pathogenesis.
@en
prefLabel
Lipotoxic lethal and sublethal ...... elevance to NASH pathogenesis.
@en
P2860
P356
P1476
Lipotoxic lethal and sublethal ...... relevance to NASH pathogenesis
@en
P2093
Harmeet Malhi
Samar H Ibrahim
P2860
P304
P356
10.1194/JLR.R066357
P577
2016-04-05T00:00:00Z